Indictment alleges illegal kickback payments tied to patient access for high-payout wound-care procedures, as prosecutors claim registered nurses received percentage-based compensation for directing Medicare beneficiaries toward costly skin-substitute treatments billed through Tesar’s Sarasota practice.
WASHINGTON, DC, August 21, 2026 — Federal prosecutors have accused Sarasota nurse practitioner Leigh Tesar of building a lucrative wound-care referral network that allegedly paid two registered nurses to direct Medicare beneficiaries toward her practice, where expensive skin substitutes generated extraordinary reimbursements from the taxpayer-funded insurance program.
The Justice Department’s official announcement and linked federal indictment allege that Tesar, Walter Presha Jr., and Koby Evans participated in an eighteen-month arrangement that produced more than $118 million in Medicare billings and about $61 million in payments before investigators intervened.
The allegations concern Medicare beneficiaries, a population including older adults, people with qualifying disabilities, and patients with serious illnesses, while the indictment specifically says some wounds would not heal because the patients receiving the disputed allografts were terminally ill.
Tesar, Presha, and Evans have been charged, but they have not been convicted, and every allegation in the indictment remains subject to challenge through motions, negotiations, evidentiary hearings, or a trial where prosecutors would carry the burden of proving guilt beyond a reasonable doubt.
Nurses Allegedly Became Patient-Referral Agents
The indictment identifies Tesar as a licensed nurse practitioner in Sarasota County, Presha as a licensed registered nurse in Manatee County, and Evans as a licensed registered nurse in Hillsborough County, placing three credentialed medical professionals at the center of the alleged arrangement.
According to prosecutors, Tesar operated Tesar Primecare, a Florida company enrolled with Medicare as a single- or multispecialty clinic or group practice in Sarasota, while Presha owned Universal Nursing and Wellness and registered W.P. Enterprises, and Evans owned Healing His Way.
Those business entities matter because prosecutors contend they supplied the commercial structure and bank accounts through which purported sales activity could be documented, referral compensation could be transmitted, and the underlying relationship among the practitioner, nurses, patients, and product distributor could be concealed.
The indictment says a Pennsylvania wound-product business, identified publicly only as Company-I, marketed and sold allografts to Tesar and Primecare while engaging Presha, Evans, and other participants under contracts that characterized them as sales representatives for the distributor’s products.
Prosecutors allege those agreements were shams because Presha and Evans did not principally perform genuine product-sales work; instead, they identified Medicare beneficiaries with wounds and referred those patients to Tesar in exchange for bribes or kickbacks tied to reimbursed allograft applications.
That distinction is central to the government’s theory because lawful medical-product promotion generally compensates legitimate commercial services, whereas federal law prohibits knowingly offering, paying, soliciting, or receiving remuneration intended to induce referrals for items or services reimbursable by a federal healthcare program.
Percentage Payments Allegedly Followed Medicare Revenue
The indictment portrays the compensation formula as directly connected to the expensive products used on referred patients, alleging that Tesar communicated invoice totals and calculated a twenty-percent share rather than paying the nurses a fixed salary unrelated to patient volume or Medicare reimbursement.
In one exchange described by the grand jury, Tesar allegedly told Presha that his accumulated invoices exceeded $4.06 million and then calculated twenty percent as approximately $813,925, language prosecutors will likely present as evidence that compensation tracked product billing rather than conventional nursing work.
Another alleged message introduced Evans to an owner of Company-I by emphasizing that Evans already had several patients who could begin treatment quickly, linking his value within the proposed relationship to immediate access to people whose wounds could support allograft claims.
Prosecutors further allege that Tesar later told Evans about a product costing $2,000 per square centimeter and explained that his twenty-percent compensation would therefore exceed what he received when a product cost $1,591 per square centimeter.
The indictment says Tesar sent a comparable message to Presha, explaining that the higher-priced product would increase his payment significantly and stating that she intended to move existing patients onto that product, an exchange suggesting price influenced product selection.
After discussing anticipated payments with Evans during April 2025, Tesar allegedly cautioned him that she was not supposed to discuss money with the purported sales representatives, a warning prosecutors may use to argue that participants understood the arrangement required secrecy.
During July 2025, prosecutors say Tesar emailed a Company-I owner with payments made by Primecare, individual allograft products, associated patients, and the relevant purported representatives, enabling the distributor to calculate and transmit the allegedly unlawful payments to Presha and Evans.
The indictment identifies two transfers made on August 15, 2025, alleging that Company-I deposited approximately $397,570 into the W.P. Enterprises account associated with Presha and approximately $10,998 into the Healing His Way account associated with Evans.
Those transfers support separate counts accusing Tesar of offering and paying healthcare kickbacks, Presha and Evans of receiving healthcare kickbacks, and all three defendants of participating in a conspiracy to defraud the United States while paying, soliciting, and receiving prohibited remuneration.
Searching for Wounds Inside Patient Rooms
Perhaps the most striking allegation concerns a June 2024 text exchange in which Tesar allegedly suggested moving from room to room to look for wounds and immediately acknowledged that the approach might be unlawful, according to the charging document.
Prosecutors have not established the full context of that exchange in court, yet they are likely to argue that its wording illuminates an organized search for billable conditions among people already receiving care, rather than referrals arising naturally from independent clinical judgment.
The government’s description therefore reaches beyond an ordinary dispute over coding accuracy or documentation quality, presenting the nurses’ access to patients as a valuable commercial asset that allegedly supplied Primecare with beneficiaries eligible for costly, repeatedly billed interventions.
Medicare primarily ensures Americans aged sixty-five and older, while also covering certain younger people with qualifying disabilities or end-stage renal disease, meaning the alleged recruitment pool could encompass beneficiaries whose age, illness, mobility limitations, or institutional care increased their dependence on professional advice.
That vulnerability makes referral integrity especially important because patients may reasonably interpret a nurse’s recommendation as medically neutral guidance, without knowing that the nurse could allegedly receive compensation when the recommendation produces reimbursable treatment through a particular practitioner or product channel.
High-Cost Allografts Powered the Alleged Scheme
The products described in the indictment were bioengineered skin substitutes, including allografts made from human placental tissue, which can be placed over qualifying open wounds to support closure or new skin growth when conservative treatment has not achieved sufficient improvement.
Medicare Part B can reimburse qualifying providers for those products and their application, but coverage depends upon medical necessity, accurate documentation, compliance with applicable coverage rules, and an underlying transaction untainted by illegal referral payments or beneficiary inducements.
Florida’s Medicare contractor required continuing wound-care records to demonstrate improvement, adherence to accepted treatment standards, evaluation of conditions affecting healing, and a treatment duration reasonably connected to the patient’s prospects for recovery, according to the indictment’s summary of coverage requirements.
Prosecutors allege that Tesar nevertheless applied or billed for allografts without first attempting or confirming appropriate conservative treatment, continued applications after wounds failed to respond, treated infected wounds, and selected particular products solely to maximize financial returns.
The indictment also says some allografts were allegedly applied to wounds that could not heal because the patients were terminally ill, an accusation that transforms the case from a reimbursement controversy into a broader examination of dignity, consent, clinical judgment, and potential patient harm.
In other instances, prosecutors contend Medicare was billed for allograft applications that never occurred, creating allegations of entirely fictitious services alongside claims involving procedures that may have happened but were allegedly unnecessary, improperly induced, falsely documented, or ineligible for reimbursement.
Gifts and Waived Costs Allegedly Encouraged Treatment
The alleged recruitment effort did not stop with payments to nurses, because the indictment also accuses Tesar, the purported representatives, and others of encouraging beneficiaries to begin or continue expensive treatment through misleading cost information and unlawful waivers of patient copayments.
Prosecutors say beneficiaries also received free medical supplies and expensive gifts, including jewelry and a leather recliner, which the government characterizes as prohibited inducements designed to influence healthcare decisions that ultimately generated substantial claims against Medicare.
Routine copayment forgiveness can concern investigators because beneficiaries with no personal financial obligation may have less reason to question cost, while providers can use the waiver as an inducement and then shift nearly the entire financial burden onto the federal program.
Expensive personal gifts can create an even clearer conflict when recipients are sick, dependent, or uncertain about treatment, since something presented as generosity may simultaneously function as consideration encouraging continued participation in a profitable course of care.
Records Allegedly Rewritten to Support Claims
The indictment alleges that Tesar and others falsified patient charts to make the allografts appear medically reasonable, necessary, and compliant, including entries claiming treatments occurred when they did not and statements asserting that Tesar personally provided earlier conservative care.
Other records allegedly moved the documented existence of wounds to earlier dates or misstated patient conditions, changes that prosecutors say helped create the appearance that coverage prerequisites had been satisfied before costly grafts were applied and billed.
These documentation accusations matter because Medicare contractors generally adjudicate claims based on codes, certifications, and records submitted by providers, leaving the program dependent on truthful charting that accurately reflects what clinicians observed, attempted, supplied, and performed.
Following a Medicare audit, Tesar allegedly removed her name as Primecare’s owner from Florida corporate records while continuing to exercise ownership and managerial control, a step prosecutors characterize as an effort to avoid scrutiny while disputed billing continued.
That accusation may become evidence of consciousness of wrongdoing, although the defense could offer an alternative business or legal explanation, and jurors would ultimately decide what inference, if any, to draw after hearing admissible evidence from both sides.
More Than $118 Million Billed in Eighteen Months
From approximately May 2024 through November 2025, the defendants allegedly caused more than $118 million in claims for wound-care products and services that prosecutors describe as unnecessary, unperformed, misrepresented, non-reimbursable, or procured through bribes and kickbacks.
Medicare paid Tesar and Primecare more than $61 million, according to the indictment, creating an unusually high-volume stream of federal reimbursement within eighteen months and giving investigators a detailed financial record to compare against messages, patient charts, invoices, and bank transfers.
Five substantive healthcare-fraud counts identify individual claims ranging from approximately $288,350 to more than $1.11 million, with corresponding Medicare payments ranging from about $199,769 to approximately $854,311 for services associated with five beneficiaries identified only by initials.
Those sample claims are not themselves proof that every dollar across the broader billing total was fraudulent, but prosecutors commonly use representative transactions to establish a recurring method while presenting aggregate billing figures to explain the alleged scheme’s scale and financial consequences.
Independent Florida news reporting on the Tesar case said all three defendants were arrested on June 18 and released that day, with Tesar placed on a $1 million bond, Presha on a $250,000 bond, and Evans on a $100,000 bond.
Release on bond allows defendants to prepare their cases outside detention while obeying court-imposed conditions, and it neither signals innocence nor establishes guilt because pretrial custody decisions address appearance and safety rather than the ultimate merits of criminal charges.
Luxury Spending and Asset Forfeiture
Prosecutors allege that proceeds from the operation supported lavish personal spending, including more than $215,000 for Tampa Bay Buccaneers tickets and a luxury suite at Raymond James Stadium, together with more than $400,000 spent acquiring fine art.
The indictment seeks forfeiture of approximately $61.6 million attributed to Tesar, roughly $3.19 million attributed to Presha, and about $263,223 attributed to Evans, representing property the government claims constitutes or derives from gross proceeds traceable to the charged offenses.
Authorities have already seized approximately $11.8 million connected to the matter, including money held in bank and investment accounts, although seizure and forfeiture allegations remain litigation positions that defendants may contest before the government permanently takes ownership.
Early asset restraints can profoundly shape a complex defense by limiting access to disputed funds, but courts must also consider constitutional protections, traceability requirements, third-party interests, and whether specific property is sufficiently connected to the alleged criminal proceeds.
Charges Carry Serious Federal Exposure
Tesar faces five substantive healthcare-fraud counts, a conspiracy count, and two counts alleging the payment of healthcare kickbacks, while Presha and Evans face the conspiracy charge and separate counts alleging receipt of the identified payments.
For the fraud counts, prosecutors must prove a knowing and willful scheme involving materially false representations connected to a healthcare benefit program, while the defense may dispute intent, medical necessity, documentation responsibility, billing knowledge, causation, or the characterization of particular services.
The Anti-Kickback Statute separately focuses on remuneration intended to induce or reward federally reimbursable referrals, making the alleged percentages, patient-specific communications, distributor contracts, banking records, and warnings about discussing money potentially significant evidence of purpose and knowledge.
Presha and Evans could argue that payments reflected bona fide sales activity or another lawful service, while Tesar could contest whether she controlled Company-I’s compensation decisions, but the government will likely emphasize the alleged patient sourcing and percentage calculations.
Because conspiracy liability can extend beyond a defendant’s personal acts, prosecutors will attempt to show a shared unlawful objective and knowing participation, whereas each defense will likely seek to separate individual conduct, communications, responsibilities, and financial benefit from the broader narrative.
A Case Within a Historic National Takedown
The Tesar prosecution emerged from the Justice Department’s 2026 National Health Care Fraud Takedown, which announced charges against 455 defendants, including ninety doctors and other licensed professionals, across schemes involving more than $6.5 billion in allegedly false claims.
Federal officials said cases were brought across fifty-six judicial districts and forty-five states and territories, while coordinated authorities seized more than $182 million in cash, residences, vehicles, jewelry, and other property during the wider enforcement initiative.
The scale reflects a data-driven strategy in which investigators compare billing patterns across providers, products, beneficiaries, and regions, then combine statistical anomalies with communications, records, witness evidence, financial transfers, and searches to determine whether extraordinary reimbursement reflects legitimate care or intentional fraud.
Skin-substitute cases have become especially prominent because very high per-square-centimeter reimbursement created powerful incentives throughout the supply chain, potentially rewarding manufacturers, distributors, marketers, practitioners, and referral sources when more expensive products were placed over larger wound areas or used repeatedly.
The Tesar allegations show prosecutors are examining every participant in that chain, including clinicians who order and apply products, nurses who locate or refer patients, distributors that pass along commissions, companies that receive funds, and providers responsible for documentation and claims.
Why the Nursing Allegations Matter
Nurses often enter homes, facilities, and patient rooms at moments when families need trusted guidance, so allegations that clinical access was monetized through undisclosed referral compensation can damage confidence far beyond one practitioner, company, or criminal case.
Healthcare organizations can reduce similar risks by prohibiting compensation tied to federal-program referrals, independently reviewing high-cost product utilization, auditing ownership and sales relationships, monitoring copayment waivers, and requiring documented clinical justification before repeated graft applications.
Compliance programs should also provide nurses and other employees with confidential channels to report unusual commissions, pressure to identify billable patients, instructions to conceal financial discussions, extravagant beneficiary gifts, or records that appear inconsistent with treatments actually delivered.
For beneficiaries and families, practical warning signs can include unexplained product changes, repeated applications without visible improvement, pressure to continue after clinical deterioration, gifts connected to treatment decisions, waived costs offered without financial review, and reluctance to coordinate with established physicians.
No warning sign independently proves fraud, and patients should not discontinue medically necessary wound care without appropriate clinical advice, but questions about product names, treatment goals, alternatives, progress measurements, costs, and referring relationships can support better-informed consent.
What Happens Next
The prosecution team includes trial attorneys from the Justice Department’s National Rapid Response Strike Force and Florida Strike Force, while a Middle District of Florida federal prosecutor is handling the government’s forfeiture effort involving the seized and traceable assets.
The next stages may include evidence production, expert review of wound records, challenges to searches or statements, disputes over the admissibility and context of electronic communications, negotiations over possible resolutions, and eventually a trial if the parties do not reach agreements.
Clinical experts may be asked to distinguish legitimate allograft treatment from unnecessary or futile applications, while coding and reimbursement specialists could explain coverage rules, claim submissions, contractor policies, acquisition costs, copayments, and how payments moved through the alleged network.
The government’s text messages and banking records may appear powerful when read in the indictment, but a charging document presents only the prosecution’s theory, and the defendants have not yet had a comparable opportunity to test witnesses or present competing evidence publicly.
Readers following comparable fraud, extradition, asset-seizure, and cross-border enforcement developments can find continuing long-form coverage through the Amicus International Consulting news and analysis hub, where complex allegations are examined alongside their legal, financial, and reputational consequences.
Broader resources from Amicus International Consulting emphasize that public accusations can create lasting search records and international consequences, yet responsible analysis must distinguish allegations from findings and avoid treating an indictment as though it were a conviction.
For now, the Tesar case presents a stark federal allegation that bedside access, professional credibility, expensive medical products, and percentage-based payments became parts of one referral engine, while the courtroom process must determine whether prosecutors can transform that allegation into proof beyond a reasonable doubt.
